Lepu Biopharma Statistics
Total Valuation
Lepu Biopharma has a market cap or net worth of HKD 4.93 billion. The enterprise value is 5.13 billion.
Market Cap | 4.93B |
Enterprise Value | 5.13B |
Important Dates
The next estimated earnings date is Thursday, November 21, 2024.
Earnings Date | Nov 21, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Lepu Biopharma has 1.71 billion shares outstanding. The number of shares has increased by 0.31% in one year.
Shares Outstanding | 1.71B |
Shares Change (YoY) | +0.31% |
Shares Change (QoQ) | +0.64% |
Owned by Insiders (%) | 35.28% |
Owned by Institutions (%) | 4.47% |
Float | 645.88M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 21.76 |
PB Ratio | 5.01 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -65.68 |
EV / Sales | 23.26 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 85.91.
Current Ratio | 0.75 |
Quick Ratio | 0.73 |
Debt / Equity | 85.91 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -28.86 |
Financial Efficiency
Return on equity (ROE) is -10.26% and return on invested capital (ROIC) is -17.06%.
Return on Equity (ROE) | -10.26% |
Return on Assets (ROA) | -11.33% |
Return on Capital (ROIC) | -17.06% |
Revenue Per Employee | 448,798 |
Profits Per Employee | -158,925 |
Employee Count | 429 |
Asset Turnover | 0.08 |
Inventory Turnover | 1.86 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.63% in the last 52 weeks. The beta is -0.45, so Lepu Biopharma's price volatility has been lower than the market average.
Beta (5Y) | -0.45 |
52-Week Price Change | -45.63% |
50-Day Moving Average | 2.94 |
200-Day Moving Average | 3.68 |
Relative Strength Index (RSI) | 49.47 |
Average Volume (20 Days) | 2,529,958 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Lepu Biopharma had revenue of HKD 220.36 million and -78.03 million in losses. Loss per share was -0.05.
Revenue | 220.36M |
Gross Profit | 173.55M |
Operating Income | -471.44M |
Pretax Income | -91.72M |
Net Income | -78.03M |
EBITDA | -381.20M |
EBIT | -471.44M |
Loss Per Share | -0.05 |
Balance Sheet
The company has 620.27 million in cash and 832.61 million in debt, giving a net cash position of -212.34 million or -0.12 per share.
Cash & Cash Equivalents | 620.27M |
Total Debt | 832.61M |
Net Cash | -212.34M |
Net Cash Per Share | -0.12 |
Equity (Book Value) | 969.21M |
Book Value Per Share | 0.57 |
Working Capital | -259.74M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 78.76%, with operating and profit margins of -213.94% and -35.41%.
Gross Margin | 78.76% |
Operating Margin | -213.94% |
Pretax Margin | -41.62% |
Profit Margin | -35.41% |
EBITDA Margin | -172.99% |
EBIT Margin | -213.94% |
FCF Margin | n/a |
Dividends & Yields
Lepu Biopharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.31% |
Shareholder Yield | -0.31% |
Earnings Yield | -1.63% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |